Teva Pharmaceutical Industries Ltd (TEVA) — Cash Flow Reinvestment Rate
Teva Pharmaceutical Industries Ltd (TEVA) has a Cash Flow Reinvestment Rate of 0.14x as of June 2026, reinvesting ILA102.58 Million (capex ILA101.58 Million plus investments ILA-1.00 Million) from operating cash flow of ILA721.91 Million. See TEVA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Teva Pharmaceutical Industries Ltd Cash Flow Reinvestment Rate (1991–2025)
Historical reinvestment intensity for Teva Pharmaceutical Industries Ltd across 34 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Teva Pharmaceutical Industries Ltd.
Annual Cash Flow Reinvestment Rate for Teva Pharmaceutical Industries Ltd (1991–2025)
Year-by-year capital reinvestment analysis for Teva Pharmaceutical Industries Ltd. See Teva Pharmaceutical Industries Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (ILA) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | ILA557.32 Million | ILA3.10 Billion | ILA542.32 Million | ▼ -57.6% |
| 2024 | 0.42x | ILA529.00 Million | ILA1.25 Billion | ILA498.00 Million | ▼ -57.4% |
| 2023 | 0.99x | ILA1.36 Billion | ILA1.37 Billion | ILA526.00 Million | ▲ +187.1% |
| 2022 | 0.35x | ILA551.00 Million | ILA1.59 Billion | ILA548.00 Million | ▼ -59.7% |
| 2021 | 0.86x | ILA687.00 Million | ILA798.00 Million | ILA562.00 Million | ▲ +68.6% |
| 2020 | 0.51x | ILA621.00 Million | ILA1.22 Billion | ILA578.00 Million | ▲ +119.8% |
| 2019 | 0.23x | ILA125.00 Million | ILA538.00 Million | ILA119.00 Million | ▼ -26.2% |
| 2018 | 0.31x | ILA770.00 Million | ILA2.45 Billion | ILA651.00 Million | ▲ +2.8% |
| 2017 | 0.31x | ILA1.07 Billion | ILA3.51 Billion | ILA874.00 Million | ▼ -95.6% |
| 2016 | 7.01x | ILA36.64 Billion | ILA5.22 Billion | ILA901.00 Million | ▲ +1300.5% |
| 2015 | 0.50x | ILA2.77 Billion | ILA5.54 Billion | ILA772.00 Million | ▲ +104.9% |
| 2014 | 0.24x | ILA1.25 Billion | ILA5.13 Billion | ILA929.00 Million | ▼ -33.6% |
| 2013 | 0.37x | ILA1.19 Billion | ILA3.24 Billion | ILA1.03 Billion | ▲ +52.4% |
| 2012 | 0.24x | ILA1.10 Billion | ILA4.57 Billion | ILA1.10 Billion | ▼ -5.2% |
| 2011 | 0.25x | ILA1.05 Billion | ILA4.13 Billion | ILA1.05 Billion | ▲ +48.4% |
| 2010 | 0.17x | ILA710.00 Million | ILA4.14 Billion | ILA710.00 Million | ▼ -19.5% |
| 2009 | 0.21x | ILA719.00 Million | ILA3.37 Billion | ILA719.00 Million | ▲ +1.1% |
| 2008 | 0.21x | ILA681.00 Million | ILA3.23 Billion | ILA681.00 Million | ▼ -29.5% |
| 2007 | 0.30x | ILA542.00 Million | ILA1.81 Billion | ILA542.00 Million | ▲ +57.8% |
| 2006 | 0.19x | ILA390.00 Million | ILA2.06 Billion | ILA390.00 Million | ▼ -16.3% |
| 2005 | 0.23x | ILA310.10 Million | ILA1.37 Billion | ILA310.10 Million | ▼ -9.1% |
| 2004 | 0.25x | ILA311.00 Million | ILA1.25 Billion | ILA311.00 Million | ▼ -24.8% |
| 2003 | 0.33x | ILA207.50 Million | ILA626.60 Million | ILA207.50 Million | ▼ -27.0% |
| 2002 | 0.45x | ILA160.40 Million | ILA353.70 Million | ILA160.40 Million | ▼ -7.6% |
| 2001 | 0.49x | ILA134.07 Million | ILA273.15 Million | ILA134.07 Million | ▼ -9.1% |
| 2000 | 0.54x | ILA89.42 Million | ILA165.63 Million | ILA89.42 Million | ▲ +23.6% |
| 1999 | 0.44x | ILA67.07 Million | ILA153.61 Million | ILA67.07 Million | ▼ -77.4% |
| 1998 | 1.93x | ILA135.60 Million | ILA70.20 Million | ILA135.60 Million | ▲ +489.8% |
| 1997 | 0.33x | ILA63.40 Million | ILA193.60 Million | ILA63.40 Million | ▼ -69.3% |
| 1995 | 1.07x | ILA112.60 Million | ILA105.40 Million | ILA112.60 Million | ▼ -48.7% |
| 1994 | 2.08x | ILA79.50 Million | ILA38.20 Million | ILA79.50 Million | ▲ +73.2% |
| 1993 | 1.20x | ILA45.30 Million | ILA37.70 Million | ILA45.30 Million | ▲ +24.1% |
| 1992 | 0.97x | ILA27.30 Million | ILA28.20 Million | ILA27.30 Million | ▼ -60.5% |
| 1991 | 2.45x | ILA22.30 Million | ILA9.10 Million | ILA22.30 Million | — |